Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
41
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Wallbox
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Subsidy Cuts Will Strain EV Demand Yet Resilience Will Emerge
Key Takeaways Revenue growth opportunities from EV adoption and renewables are tempered by risks from reduced subsidies, shifting technologies, and regional policy changes. Margin and profitability gains face headwinds from high R&D costs, supply chain pressures, and limited geographic diversification.
View narrative
US$5.98
FV
27.1% undervalued
intrinsic discount
41.09%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
American Well
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Budget Cuts And Data Rules Will Cripple Healthcare Margins
Key Takeaways Heavy reliance on volatile government funding, intensifying competition, and stricter data regulations threaten margins, scalability, and long-term revenue stability. Ongoing cash burn and lacking profitability raise concerns about future equity dilution and the company's ability to sustain growth.
View narrative
US$7.50
FV
4.7% undervalued
intrinsic discount
-5.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Blink Charging
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Declining EV Revenues Will Constrain Margins Yet Enable Recovery
Key Takeaways Declining government incentives or home charging adoption could cap Blink's revenue growth, limit charging utilization, and challenge future profitability. Heightened competition, high operating costs, and potential capital needs pose significant risks to margin expansion and shareholder returns.
View narrative
US$1.00
FV
6.0% undervalued
intrinsic discount
17.32%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
PowerCell Sweden
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Slow Hydrogen Rollout Will Cripple Margins Yet Spur Recovery
Key Takeaways Prolonged infrastructure delays and rapid battery advancements threaten sustained demand and revenue stability despite strong partnerships and policy support. High capital intensity and volatile order flow expose the company to risks of margin pressure, potential dilution, and unpredictable profitability.
View narrative
SEK 30.00
FV
8.4% undervalued
intrinsic discount
19.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Innate Pharma
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Global Pricing Pressures Will Constrain Margins While Recovery Will Emerge
Key Takeaways Dependence on milestone payments and uncertain product approvals causes earnings volatility and risks reliable long-term growth. Intensifying pricing pressures and lack of significant commercial revenues threaten margins and may necessitate equity dilution or costly financing.
View narrative
€2.49
FV
21.1% undervalued
intrinsic discount
9.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Leonteq
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Digital Transformation And Compliance Resolution Will Unlock New Markets
Key Takeaways Improved compliance and digitalization initiatives are expected to boost client confidence, drive operating efficiency, and support revenue and margin growth. Expansion into new products and markets aims to diversify revenue streams, reduce earnings volatility, and position the company for sustained profitability.
View narrative
CHF 20.50
FV
11.0% undervalued
intrinsic discount
13.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
1 day ago
author updated this narrative
Halozyme Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Subcutaneous Biologics Adoption Will Expand ENHANZE's Global Reach
Key Takeaways Halozyme benefits from the global shift to subcutaneous drug delivery, driving robust royalty growth and expanding margins through its ENHANZE platform and new biologic launches. Advancing proprietary technologies and efficient operations enable value-accretive deals, increasing revenue streams and supporting sustained earnings growth.
View narrative
US$70.00
FV
3.9% undervalued
intrinsic discount
17.71%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
54
users have followed this narrative
2 days ago
author updated this narrative
Organon
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
New Product Launches And Biosimilars Will Open Global Healthcare Markets
Key Takeaways New product launches and biosimilars adoption are driving market share growth, while portfolio shifts and operational efficiencies support stronger margins. Expanding presence in global and emerging markets, together with improving financial flexibility, positions the company for sustained revenue growth and strategic investments.
View narrative
US$13.17
FV
28.3% undervalued
intrinsic discount
1.17%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
27
users have followed this narrative
2 days ago
author updated this narrative
AsiaInfo Technologies
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
5G Private Networks And AI Will Shape Digital Future
Key Takeaways High-margin growth is driven by 5G private networks and AI solutions for enterprises, supported by government digitalization initiatives and AsiaInfo's early market entry. Operational transformation, international expansion, and improved cash flow position the company for superior margins and diversified revenue beyond legacy business.
View narrative
HK$13.00
FV
19.1% undervalued
intrinsic discount
11.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies